To include your compound in the COVID-19 Resource Center, submit it here.

ThermoDox heat-activated liposome: Phase III started

Celsion began the double-blind, placebo-controlled, international Phase III OPTIMA trial to compare ThermoDox in combination with optimized radiofrequency ablation (RFA)

Read the full 200 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE